Sep 1, 2016
Report: Mylan tied exec pay to aggressive profit targets Acorda Therapeutics CEO Dr. Ron Cohen on experiences that Mylan tied government pay to aggressive revenue targets.
seen from Russia
seen from United States
seen from Poland
seen from Maldives
seen from United States
seen from United States
seen from China
seen from Sweden
seen from China
seen from Poland
seen from United Kingdom
seen from United States
seen from United States
seen from United States
seen from United States
seen from United Kingdom
seen from United States
seen from China
seen from Russia
seen from United States
Report: Mylan tied exec pay to aggressive profit targets Acorda Therapeutics CEO Dr. Ron Cohen on experiences that Mylan tied government pay to aggressive revenue targets.